Cardiovascular pharmacology — Now and future.

[Cardiovascular pharmacology].

MargaretAcara Martin W. Adler Edson X. Albuquerque Julius C. Allen William D. Atchison Robert L. Balster Paul Bass MichaelA. Beaven Donald M. Bers C. Paul Bianchi David A. Blake Floyd E. Bloom Peter G. Bradford Craig D. Brater Carl K. Buckner Theodore J. Cicero Marlene L. Cohen Charles R. Craig E. E. Daniel William C. de Groat Louis Diamond Walter R. Dixon Thomas V. Dunwiddie Hugh L. Evans Jerr...

Cardiovascular and Renal Pharmacology

Cardiovascular Pharmacology

Anti-ischemic drug therapy during anesthesia is indicated whenever evidence of myocardial ischemia exists. The treatment of ischemia during anesthesia is complicated by the ongoing stress of surgery, blood loss, concurrent organ ischemia, and the patient’s inability to interact with the anesthesiologist. Nonetheless, the fundamental principles of treatment remain the same as in the unanesthetiz...

Now and in the Future

that presented by Dr. T.A. Sanborn in his editorial in this issue.1 I stake no claim to being correct, only different, because our different views derive not from facts but from uncertainties. I see two crucial uncertainties in laser angioplasty: which of the new interventional systems will be most effective, and will answers derived from peripheral vascular interventions apply to coronary arte...

ODE Architect: Now and Future

This article describes current compatibility issues with ODE Architect software suite and 64-bit Windows operating systems, and proposes viable alternatives using virtual machine environment and cloud computing.